Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iBio, Inc. stock logo
IBIO
iBio
$1.72
-9.5%
$0.00
$1.02
$23.60
$5.99M-3.513.04 million shs247,517 shs
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
C$0.11
C$0.11
C$0.02
C$0.16
C$952KN/A3.16 million shs1.31 million shs
Insperity, Inc. stock logo
NSP
Insperity
$108.93
-0.5%
$102.85
$90.80
$128.91
$4.10B1.14327,771 shs232,271 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iBio, Inc. stock logo
IBIO
iBio
-1.05%+0.53%+50.00%+188,999,900.00%+188,999,900.00%
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
0.00%0.00%0.00%0.00%0.00%
Insperity, Inc. stock logo
NSP
Insperity
+0.77%+3.57%+3.62%-2.75%-8.81%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iBio, Inc. stock logo
IBIO
iBio
N/AN/AN/AN/AN/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
4.386 of 5 stars
1.04.03.33.53.11.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iBio, Inc. stock logo
IBIO
iBio
N/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
2.00
Hold$115.005.57% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iBio, Inc. stock logo
IBIO
iBio
$2.38M2.51N/AN/A$15.15 per share0.11
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AC$0.01 per share8.75C$0.00 per shareN/A
Insperity, Inc. stock logo
NSP
Insperity
$6.49B0.63$5.42 per share20.11$2.51 per share43.40

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iBio, Inc. stock logo
IBIO
iBio
-$65.01MN/A0.00N/AN/A-150.59%-52.83%N/A
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A-C$0.01N/AN/AN/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
$171.38M$4.4624.4238.633.102.64%153.34%8.42%5/1/2024 (Confirmed)

Latest IBIO, ICO, NSP, LCT, and REDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Insperity, Inc. stock logo
NSP
Insperity
$1.84N/A-$1.84N/AN/AN/A  
2/9/2024Q2 2024
iBio, Inc. stock logo
IBIO
iBio
N/A-$2.42-$2.42-$0.42N/AN/A
2/8/2024Q4 2023
Insperity, Inc. stock logo
NSP
Insperity
$0.38$0.46+$0.08$0.40$1.57 billion$1.58 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iBio, Inc. stock logo
IBIO
iBio
N/AN/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
$2.282.09%+11.70%51.12%13 Years

Latest IBIO, ICO, NSP, LCT, and REDX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2024
Insperity, Inc. stock logo
NSP
Insperity
Quarterly$0.572.34%3/6/20243/7/20243/21/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iBio, Inc. stock logo
IBIO
iBio
0.04
0.91
0.91
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A
1.14
1.12
Insperity, Inc. stock logo
NSP
Insperity
3.95
1.11
1.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
iBio, Inc. stock logo
IBIO
iBio
7.90%
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A
Insperity, Inc. stock logo
NSP
Insperity
93.44%

Insider Ownership

CompanyInsider Ownership
iBio, Inc. stock logo
IBIO
iBio
1.12%
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A
Insperity, Inc. stock logo
NSP
Insperity
5.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
iBio, Inc. stock logo
IBIO
iBio
263.48 million3.45 millionN/A
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A9.07 millionN/ANot Optionable
Insperity, Inc. stock logo
NSP
Insperity
4,40037.65 million35.58 millionOptionable

IBIO, ICO, NSP, LCT, and REDX Headlines

SourceHeadline
Rehabbing Bernhard Langer Inspired By Aaron Rodgers, Targets Return to Golf at InsperityRehabbing Bernhard Langer Inspired By Aaron Rodgers, Targets Return to Golf at Insperity
progolfweekly.com - April 25 at 2:59 AM
Insperity (NSP) to Release Quarterly Earnings on WednesdayInsperity (NSP) to Release Quarterly Earnings on Wednesday
marketbeat.com - April 24 at 6:45 AM
9,900 Shares in Insperity, Inc. (NYSE:NSP) Acquired by Louisiana State Employees Retirement System9,900 Shares in Insperity, Inc. (NYSE:NSP) Acquired by Louisiana State Employees Retirement System
marketbeat.com - April 24 at 4:54 AM
Big As Texas music festival, PGA Tour Champions, top Montgomery County May eventsBig As Texas music festival, PGA Tour Champions, top Montgomery County May events
houstonchronicle.com - April 23 at 11:25 AM
4 Reasons You Need a Strong People Strategy4 Reasons You Need a Strong People Strategy
inc.com - April 22 at 2:01 PM
Loud quitting: What is it and how does it affect businesses?'Loud quitting': What is it and how does it affect businesses?
msn.com - April 22 at 9:00 AM
The Upskilling Strategy That Your Business NeedsThe Upskilling Strategy That Your Business Needs
forbes.com - April 22 at 9:00 AM
What is quiet cutting, and how is it difference from quiet quitting?What is quiet cutting, and how is it difference from quiet quitting?
bizjournals.com - April 21 at 2:35 PM
Insperity, Inc. (NSP)Insperity, Inc. (NSP)
finance.yahoo.com - April 20 at 2:14 PM
Why the viral trend ‘chronoworking’ is making waves among employees and employersWhy the viral trend ‘chronoworking’ is making waves among employees and employers
msn.com - April 20 at 9:14 AM
Mackenzie Financial Corp Buys 34,010 Shares of Insperity, Inc. (NYSE:NSP)Mackenzie Financial Corp Buys 34,010 Shares of Insperity, Inc. (NYSE:NSP)
marketbeat.com - April 20 at 5:57 AM
Insperity First Quarter Earnings Conference Call Wednesday, May 1Insperity First Quarter Earnings Conference Call Wednesday, May 1
businesswire.com - April 19 at 9:00 AM
Insperity, Inc. (NSP) Interactive Stock Chart - Yahoo FinanceInsperity, Inc. (NSP) Interactive Stock Chart - Yahoo Finance
finance.yahoo.com - April 17 at 1:44 AM
After Quiet Quitting, Resenteeism Is the New Trend Affecting Workplaces; How Can It Be Prevented?After Quiet Quitting, Resenteeism Is the New Trend Affecting Workplaces; How Can It Be Prevented?
msn.com - April 16 at 10:43 AM
14 events to attend this spring season in The Woodlands area14 events to attend this spring season in The Woodlands area
communityimpact.com - April 12 at 3:11 PM
Worried About HR Burnout? 20 Strategies To Prevent Empathy FatigueWorried About HR Burnout? 20 Strategies To Prevent 'Empathy Fatigue'
forbes.com - April 12 at 3:11 PM
The Astros Host Rival Texas Rangers and NL Powerhouse Atlanta Braves in Six-Game HomestandThe Astros Host Rival Texas Rangers and NL Powerhouse Atlanta Braves in Six-Game Homestand
mlb.com - April 12 at 3:11 PM
Bernhard Langer Injury Update: Achilles Tear Couldn’t Hold Back the ChampionBernhard Langer Injury Update: Achilles Tear Couldn’t Hold Back the Champion
msn.com - April 12 at 3:11 PM
Dude Perfect Receives $100 Million Capital InfusionDude Perfect Receives $100 Million Capital Infusion
dmagazine.com - April 12 at 3:11 PM
Cariloop corrals $20M to expand caregiver solutionsCariloop corrals $20M to expand caregiver solutions
axios.com - April 11 at 6:13 PM
20 Strategies To Drive Employee Retention Through Holistic Well-Being20 Strategies To Drive Employee Retention Through Holistic Well-Being
forbes.com - April 11 at 6:13 PM
Business Expo to focus on Black and Brown entrepreneur supportBusiness Expo to focus on Black and Brown entrepreneur support
dailyherald.com - April 11 at 6:13 PM
The Dangers of Fake ApplicantsThe Dangers of Fake Applicants
comstocksmag.com - April 11 at 6:13 PM
New workplace trend ‘resenteeism’ has employees working less hard because they hate their jobsNew workplace trend ‘resenteeism’ has employees working less hard because they hate their jobs
nypost.com - April 10 at 3:37 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

iBio logo

iBio

NYSE:IBIO
iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel. The company is also developing vaccine candidates, including IBIO-101, an antibody to reduce tumor growth; Endostatin E4 peptide for use in chemotherapy and immunotherapy; Trop-2 for the treatment Trop-2 positive cancers; MUC16, a tumor-associated epitope; anti-EGFRvIII antibody to treat glioblastoma and other cancers; CCR8 protein candidate for treatment of various cancers; PD-1 agonist for the treatment of rheumatoid arthritis and other inflammatory diseases; and IBIO-400 for the treatment of classical swine fever. iBio, Inc. has agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; and a research collaboration with the National Institute of Allergy and Infectious Diseases to investigate the potential of the company's AI-driven epitope steering platform for the development of a vaccine for Lassa fever. The company was incorporated in 2008 and is headquartered in Bryan, Texas.
iCo Therapeutics logo

iCo Therapeutics

CVE:ICO
iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed drug candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.
Insperity logo

Insperity

NYSE:NSP
Insperity, Inc. engages in the provision of human resources (HR) and business solutions to improve business performance for small and medium-sized businesses primarily in the United States. It offers its HR services through its workforce optimization and workforce synchronization solutions that include a range of human resources functions, such as payroll and employment administration, employee benefits, workers' compensation, government compliance, performance management, and training and development services. The company also provides Insperity Premier, a cloud-based human capital management platform that offers professional employer organization HR outsourcing solutions to its clients; people management services; and employer liability management services, as well as solutions for middle market. In addition, it offers MarketPlace, an e-commerce portal that offers a range of products and services; and Workforce Acceleration, a human capital management and payroll services solution; integrated payroll; benefits administration; HR administration and employee onboarding; time and attendance; performance management; reporting and analytics; recruiting; employment screening; retirement; and insurance services. The company was formerly known as Administaff, Inc. and changed its name to Insperity, Inc. in March 2011. Insperity, Inc. was founded in 1986 and is headquartered in Kingwood, Texas.